Blueshift Asset Management, LLC Takeda Pharmaceutical CO LTD Transaction History

Blueshift Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$13.12 - $15.03 $20,060 - $22,980	-1,529 Reduced 11.71%	11,523 $162,000
Q1 2022 May 12, 2022	BUY	$13.54 - $15.35 $176,724 - $200,348	13,052 New	13,052 $187,000
Q1 2021 May 06, 2021	SELL	$16.71 - $19.9 $395,692 - $471,231	-23,680 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $390,921 - $481,856	-25,401 Reduced 51.75%	23,680 $431,000
Q3 2020 Nov 13, 2020	BUY	$17.1 - $19.19 $839,285 - $941,864	49,081 New	49,081 $876,000

Q1 2020 May 14, 2020	SELL	$13.02 - $20.31 $927,245 - $1.45 Million	-71,217 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $1.2 Million - $1.48 Million	71,217 New	71,217 $1.41 Million
Q3 2019 Nov 12, 2019	SELL	$16.15 - $17.99 $536,696 - $597,843	-33,232 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $95,484 - $118,001	-5,759 Reduced 14.77%	33,232 $588,000
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $651,149 - $839,086	38,991 New	38,991 $794,000

340

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.